Millennium Management’s Biofrontera BFRI Stock Holding History

Millennium Management’s Portfolio BFRI Stock Details BFRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,095	Closed	-$11K	–	5868
2024 Q4	$11K	Buy	+10,095	New	+$9.55K	﹤0.01%	5775

Other funds holding BFRI

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's BFRI Position: Q1 2025 in Review

Millennium Management sold out of Biofrontera (BFRI) in Q1 2025, closing a stake of 10,095 shares — an estimated $11K sold.

Millennium Management first reported a position in BFRI in Q4 2024 and held it in 1 quarter. The position peaked at $11K in Q4 2024. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2025.

Millennium Management reported no remaining Biofrontera position as of Q1 2025 after selling out during the quarter.
Millennium Management sold 10,095 Biofrontera shares in Q1 2025, an estimated $11K.
Millennium Management first reported a position in Biofrontera in Q4 2024 and held it in 1 quarter.
Millennium Management's Biofrontera position peaked at $11K in Q4 2024.
12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.